Shuttle Pharmaceuticals, Inc.
🏢 View company profile →9Patents
9Active
9Granted
43Portfolio score
Filing activity: Mar 3, 2015 → Dec 4, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9809539B2 | Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof | Human Necessities | 4 | Active |
| US10745352B2 | Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof | Human Necessities | 0 | Active |
| US11584733B2 | Selective histone deacetylase inhibitors for the treatment of human disease | Human Necessities | 0 | Active |
| US12357650B2 | Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation | Human Necessities | 0 | Active |
| US11654157B2 | Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation | Human Necessities | 0 | Active |
| US11034667B2 | Selective histone deacetylase inhibitors for the treatment of human disease | Human Necessities | 0 | Active |
| US12077515B2 | Selective histone deacetylase inhibitors for the treatment of human disease | Human Necessities | 0 | Active |
| US10730834B2 | Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof | Human Necessities | 0 | Active |
| US11407723B2 | Selective histone deacetylase inhibitors for the treatment of human disease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.